Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046851330> ?p ?o ?g. }
- W2046851330 endingPage "775" @default.
- W2046851330 startingPage "766" @default.
- W2046851330 abstract "When a standard dose of statins fails to achieve lipid control in patients at high risk for coronary artery disease (CAD), increasing the statin dosage or co-administration of additional agents is recommended. The aim of this study was to compare the safety and lipid-lowering efficacy of doubling the standard statin dose (STAT2) to that of co-administering ezetimibe 10 mg/day (EZE+statin) in Canadian patients at high CAD risk with persistent hyperlipidemia upon statin treatment.Six-week, open-label, randomized, multicentre study. The primary outcome was the change in plasma LDL-C and secondary measures included the change in additional lipid parameters. Safety was assessed with the incidence of emergent adverse events (AEs).Eight hundred eighty-five patients (EZE+statin, n=586; STAT2, n=299) completed the study. The mean (SD) percent change in low-density lipoprotein cholesterol (LDL-C) was - 30.9% (18.2) for the EZE+statin group and -18.4% (19.0) for the STAT2 group (p=0.001). Percent and absolute decreases in total cholesterol (TC), triglycerides and the TC to high-density lipoprotein cholesterol ratio (TC/HDL-C) were significantly greater for the EZE+statin group (p = 0.001). After 6 weeks of treatment, 70% of the patients in the EZE+statin group and 48% of patients in the STAT2 group (OR=2.45, p<0.001) achieved target LDL-C levels of<2.5 mmol/l. Incidence of AEs was similar between groups, with the exception of a higher incidence of muscle disorders in the STAT2 group.In patients at high CAD risk who are above the LDL-C target while on statin monotherapy, co-administration of ezetimibe is well tolerated and more effective in improving the lipid profile compared to doubling the existing statin dose." @default.
- W2046851330 created "2016-06-24" @default.
- W2046851330 creator A5010125501 @default.
- W2046851330 creator A5015903422 @default.
- W2046851330 creator A5019371815 @default.
- W2046851330 creator A5021984394 @default.
- W2046851330 creator A5065774384 @default.
- W2046851330 date "2011-01-01" @default.
- W2046851330 modified "2023-10-18" @default.
- W2046851330 title "Effectiveness and tolerability of ezetimibe co-administered with statins versus statin dose-doubling in high-risk patients with persistent hyperlipidemia: The EZE(STAT)2 trial" @default.
- W2046851330 cites W1510658613 @default.
- W2046851330 cites W1957219571 @default.
- W2046851330 cites W1978435932 @default.
- W2046851330 cites W1994618005 @default.
- W2046851330 cites W2001375687 @default.
- W2046851330 cites W2004936310 @default.
- W2046851330 cites W2025041596 @default.
- W2046851330 cites W2084675507 @default.
- W2046851330 cites W2088787655 @default.
- W2046851330 cites W2089356907 @default.
- W2046851330 cites W2100715406 @default.
- W2046851330 cites W2106343349 @default.
- W2046851330 cites W2116404316 @default.
- W2046851330 cites W2124507294 @default.
- W2046851330 cites W2130760108 @default.
- W2046851330 cites W2131970516 @default.
- W2046851330 cites W2132211266 @default.
- W2046851330 cites W2136295087 @default.
- W2046851330 cites W2139952972 @default.
- W2046851330 cites W2140072878 @default.
- W2046851330 cites W2145866410 @default.
- W2046851330 cites W2150093840 @default.
- W2046851330 cites W2150799450 @default.
- W2046851330 cites W2155121555 @default.
- W2046851330 cites W2163106819 @default.
- W2046851330 cites W2164551379 @default.
- W2046851330 cites W2165674458 @default.
- W2046851330 cites W2167067204 @default.
- W2046851330 cites W2169523655 @default.
- W2046851330 cites W2170281452 @default.
- W2046851330 cites W2183307246 @default.
- W2046851330 cites W2247997571 @default.
- W2046851330 cites W2279238885 @default.
- W2046851330 cites W2606936918 @default.
- W2046851330 doi "https://doi.org/10.5114/aoms.2011.25550" @default.
- W2046851330 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3258811" @default.
- W2046851330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22291820" @default.
- W2046851330 hasPublicationYear "2011" @default.
- W2046851330 type Work @default.
- W2046851330 sameAs 2046851330 @default.
- W2046851330 citedByCount "7" @default.
- W2046851330 countsByYear W20468513302012 @default.
- W2046851330 countsByYear W20468513302013 @default.
- W2046851330 countsByYear W20468513302014 @default.
- W2046851330 countsByYear W20468513302023 @default.
- W2046851330 crossrefType "journal-article" @default.
- W2046851330 hasAuthorship W2046851330A5010125501 @default.
- W2046851330 hasAuthorship W2046851330A5015903422 @default.
- W2046851330 hasAuthorship W2046851330A5019371815 @default.
- W2046851330 hasAuthorship W2046851330A5021984394 @default.
- W2046851330 hasAuthorship W2046851330A5065774384 @default.
- W2046851330 hasBestOaLocation W20468513301 @default.
- W2046851330 hasConcept C120665830 @default.
- W2046851330 hasConcept C121332964 @default.
- W2046851330 hasConcept C126322002 @default.
- W2046851330 hasConcept C134018914 @default.
- W2046851330 hasConcept C197934379 @default.
- W2046851330 hasConcept C2776839432 @default.
- W2046851330 hasConcept C2778163477 @default.
- W2046851330 hasConcept C2778375690 @default.
- W2046851330 hasConcept C2778657065 @default.
- W2046851330 hasConcept C2779091943 @default.
- W2046851330 hasConcept C555293320 @default.
- W2046851330 hasConcept C61511704 @default.
- W2046851330 hasConcept C71924100 @default.
- W2046851330 hasConcept C90924648 @default.
- W2046851330 hasConcept C98274493 @default.
- W2046851330 hasConceptScore W2046851330C120665830 @default.
- W2046851330 hasConceptScore W2046851330C121332964 @default.
- W2046851330 hasConceptScore W2046851330C126322002 @default.
- W2046851330 hasConceptScore W2046851330C134018914 @default.
- W2046851330 hasConceptScore W2046851330C197934379 @default.
- W2046851330 hasConceptScore W2046851330C2776839432 @default.
- W2046851330 hasConceptScore W2046851330C2778163477 @default.
- W2046851330 hasConceptScore W2046851330C2778375690 @default.
- W2046851330 hasConceptScore W2046851330C2778657065 @default.
- W2046851330 hasConceptScore W2046851330C2779091943 @default.
- W2046851330 hasConceptScore W2046851330C555293320 @default.
- W2046851330 hasConceptScore W2046851330C61511704 @default.
- W2046851330 hasConceptScore W2046851330C71924100 @default.
- W2046851330 hasConceptScore W2046851330C90924648 @default.
- W2046851330 hasConceptScore W2046851330C98274493 @default.
- W2046851330 hasLocation W20468513301 @default.
- W2046851330 hasLocation W20468513302 @default.
- W2046851330 hasLocation W20468513303 @default.
- W2046851330 hasLocation W20468513304 @default.
- W2046851330 hasOpenAccess W2046851330 @default.
- W2046851330 hasPrimaryLocation W20468513301 @default.